Patients with uveal melanoma may respond to T-cell therapy directed at an antigen that is highly expressed in the tumors, despite them not being amenable to traditional immunotherapy, suggests trial.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/targeted-t-cell-therapy-beneficial-rare-form-melanoma-2025a1000tcu?src=rss
Author :
Publish date : 2025-10-28 12:17:00
Copyright for syndicated content belongs to the linked Source.
